Joshua Rosenblat
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT) (NCT07569198) | Joshua Rosenblat | 2026-07-16 |
| Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant Depression (NCT07737990) | Joshua Rosenblat | 2026-07-01 |
| Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression (NCT05339074) | Joshua Rosenblat | 2022-08-11 |
| Ketamine for Treatment-Resistant Bipolar Disorder (NCT05004896) | Joshua Rosenblat | 2022-07-04 |
Track Joshua Rosenblat automatically
Every clearance here is in the API, with alerts when new ones post.